Lung Neoplasms
|
group |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1486
|
39
|
0.110 |
None |
1.000 |
1 |
|
2007 |
2007 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.854 |
41 |
|
2002 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.100 |
None |
1.000 |
10 |
|
1999 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.100 |
None |
1.000 |
10 |
|
1999 |
2019 |
Allergic Reaction
|
phenotype |
Immune System Diseases
|
Pathologic Function
|
197
|
1019
|
0.100 |
None |
1.000 |
3 |
2
|
2016 |
2018 |
Adult onset asthma
|
disease |
|
Disease or Syndrome
|
48
|
67
|
0.100 |
None |
1.000 |
2 |
2
|
2019 |
2019 |
Eosinophil count procedure
|
phenotype |
|
Laboratory Procedure
|
610
|
1144
|
0.100 |
None |
1.000 |
2 |
2
|
2016 |
2019 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Allergic sensitization
|
disease |
|
Disease or Syndrome
|
85
|
26
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Respiratory Tract Diseases
|
group |
Respiratory Tract Diseases
|
Disease or Syndrome
|
198
|
109
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Serum HDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
283
|
679
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Serum LDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
269
|
555
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
545
|
1440
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Blood basophil count (lab test)
|
phenotype |
|
Laboratory Procedure
|
272
|
452
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Pelvic mass
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Finding
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Uterine Neoplasms
|
group |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
32
|
1
|
0.100 |
None |
|
0 |
|
|
|
Vaginal Neoplasms
|
group |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
13
|
|
0.100 |
None |
|
0 |
|
|
|
Soft Tissue Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
145
|
|
0.100 |
None |
|
0 |
|
|
|
Low Back Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
88
|
11
|
0.100 |
None |
|
0 |
|
|
|
Urinary Retention
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Finding
|
17
|
4
|
0.100 |
None |
|
0 |
|
|
|
Liver neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1424
|
7
|
0.100 |
None |
|
0 |
|
|
|
Unconscious State
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
13
|
1
|
0.100 |
None |
|
0 |
|
|
|
Nervous System Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
68
|
1
|
0.100 |
None |
|
0 |
|
|
|